Related Experiment Video

Updated: Jul 27, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

Mitogen-activated protein kinase activation resulting from selective oncogene expression in NIH 3T3 and rat 1a cells

C Gallego1, S K Gupta, L E Heasley

  • 1Division of Basic Sciences, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.

Proceedings of the National Academy of Sciences of the United States of America
|August 15, 1992
PubMed

Insights

Oncogenes like ras, raf, and gip2 can activate mitogen-activated protein kinases (MAPKs) but this effect is cell-type specific. Oncogene-induced MAPK activation does not directly correlate with cellular transformation.

Area of Science:

  • Cellular signaling pathways
  • Oncogene research
  • Signal transduction

Background:

  • Mitogen-activated protein kinases (MAPKs) are crucial serine/threonine kinases involved in cellular responses to growth factors.
  • MAPKs integrate signals from growth factor receptors, converting tyrosine kinase activity into serine/threonine kinase activation.
  • Understanding MAPK regulation is vital for comprehending cell growth and cancer development.

Purpose of the Study:

  • To investigate how specific oncogenes influence MAPK activation in different cell types.
  • To determine if oncogene-induced MAPK activation correlates with cellular transformation.
  • To elucidate the cell-type-specific regulation of MAPK pathways by oncogenes.

Main Methods:

  • Utilized NIH 3T3 and Rat 1a fibroblast cell lines.
  • Examined the effects of expressing ras, raf, and gip2 oncogenes.
  • Assessed MAPK activity and cellular transformation levels.

Main Results:

  • In NIH 3T3 cells, ras and raf oncogenes constitutively activated MAPK, while gip2 did not.
  • In Rat 1a cells, gip2 strongly activated MAPK constitutively, but ras and raf did not.
  • The extent of oncogene-induced MAPK activation did not correlate with cellular transformation.

Conclusions:

  • Different oncogenes activate MAPK in a cell-type-selective manner.
  • The regulation of MAPK pathways by oncogenes is context-dependent.
  • Specific oncogenes alter MAPK regulation differently across various cell types, impacting cytoplasmic kinase networks.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...